Last reviewed · How we verify

FMS placebo tablets

University of Taubate · FDA-approved active Small molecule

A placebo tablet that contains no active pharmaceutical ingredient and produces therapeutic effects through the placebo effect mechanism.

At a glance

Generic nameFMS placebo tablets
SponsorUniversity of Taubate
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

Placebo tablets are inert formulations used as control comparators in clinical trials or, in some cases, as marketed products where the therapeutic benefit derives from patient expectation and the placebo effect rather than pharmacological action. FMS placebo tablets from the University of Taubate appear to be a marketed placebo product, likely used in research or clinical settings.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: